Grünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration
- The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines
- The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and intends to acquire the remaining share at the beginning of 2026
Aachen, Germany and Tokyo, Japan, 2 August 2023
Grünenthal GmbH (CEO: Gabriel Baertschi), a global, science-based, privately-owned pharmaceutical company and Kyowa Kirin Co., Ltd., (TSE:4151, President and CEO: Masashi Miyamoto, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced the successful completion of a deal to enter into a Joint Venture Collaboration for Kyowa Kirin International's established medicines portfolio.
The portfolio comprises 13 brands across six therapeutic areas primarily focused on pain management, including Abstral® and PecFent® for breakthrough cancer pain, Moventig® for opioid-induced constipation, and Adcal-D3® for osteoporosis. All products will continue to be marketed through affiliates in seven major European countries and through a network of partners in various additional territories worldwide.
"Grünenthal is a global leader in pain management. With the addition of this strong portfolio, we will be able to help more patients who suffer from various forms of pain," said Gabriel Baertschi, Chief Executive Officer, Grünenthal.
"The established medicines portfolio has a proud history of delivering life-changing value for patients. Today's announcement now means even more patients, for many years to come, will continue to benefit from the portfolio. We are enormously grateful and proud of our colleagues who have worked tirelessly to make this Joint Venture Collaboration a reality," said Jeremy Morgan, President, Kyowa Kirin International.
Grünenthal owns a 51 percent majority share in the Joint Venture Collaboration, while Kyowa Kirin owns a 49 percent share. Grünenthal intends to fully acquire the remaining 49 percent share via exercising an option at the beginning of 2026.
About Grünenthal Meds
As part of the Joint Venture Collaboration between Grünenthal GmbH and Kyowa Kirin Co., Ltd., a new enterprise has been created to market Kyowa Kirin International's established medicines portfolio, which comprises 13 brands across six therapeutic areas. This enterprise will be branded in all markets as Grünenthal Meds.
The portfolio includes medicines that deliver life-changing value for hundreds of thousands of patients. The portfolio is available in seven major European markets through affiliates and in various additional territories worldwide through a network of partners. Key products in the portfolio include Abstral® and PecFent® (Fentanyl) for breakthrough cancer pain, Moventig® (Naloxegol) for opioid-induced constipation and Adcal-D3® (calcium and vitamin D3) for osteoporosis. Visit www.grunenthalmeds.com to find out more.
About Kyowa Kirin
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based global specialty pharmaceutical company with a more than 70-year heritage, we apply cutting-edge science, including an expertise in antibody research and engineering, to address the needs of patients and society across multiple therapeutic areas including Nephrology, Oncology, Immunology/Allergy and Neurology. Across our four regions – Japan, Asia Pacific, North America and EMEA/International – we focus on our purpose, to make people smile, and are united by our shared values of commitment to life, teamwork, innovation, and integrity. You can learn more about the business of Kyowa Kirin at: https://www.kyowakirin.com/.
Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd.
About Grünenthal
Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.
Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America and the US. Our products are available in more than 100 countries. In 2022, Grünenthal employed around 4,400 people and achieved sales of € 1.7 bn.
More information: www.grunenthal.com and Grünenthal Report 2022/23 digital edition (grunenthal.com)
|
Kyowa Kirin International www.international.kyowa-kirin.com Galabank Business Park Galashiels, TD1 1QH United Kingdom Contacts for Kyowa Kirin International: Media Stacey Minton Email: Stacey.Minton@kyowakirin.com
Contacts for Kyowa Kirin Co., Ltd.: Media Hiroki Nakamura Email: media@kyowakirin.com |
Grünenthal GmbH Zieglerstr. 6 52078 Aachen Germany Media Contact: Florian Dieckmann |
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
EUROJET signs contract to provide EJ200 Engines for the recent Italian Air Force Eurofighter Order of up to 24 Aircraft27.6.2025 16:25:57 CEST | Press release
Rome, Italy, Friday, 27th June 2025 EUROJET Turbo GmbH, the consortium behind the EJ200 engine that powers the Eurofighter Typhoon, has today signed a new contract with the NATO Eurofighter & Tornado Management Agency (NETMA). Under this agreement, EUROJET will deliver up to 54 new EJ200 engines to the Italian Air Force as part of the Eurofighter Tranche I replacement. A renaissance of interest in the programme, it follows hot on the heels of the Spanish Halcón II contract announced at the end of last year.
European Marketing Distribution: MANIELE TASCA TAKES OVER PRESIDENCY OF EUROPE'S LEADING TRADE ALLIANCE EMD27.6.2025 08:30:00 CEST | Press release
Top manager from Italy emphasises continued close partnership with industry Stephanie Lotter, Director at Globus in Germany, elected to the EMD Executive Board
Invest Taicang: The 17th Taicang Day in Stuttgart Celebrates Over 30 Years of Sino-German Cooperation and Innovation26.6.2025 08:41:11 CEST | Press release
On June 25, the 17th "Taicang Day" event kicked off in Stuttgart, marking a significant milestone in the longstanding relationship between Taicang, a city in E China, and Germany. The event returned to its original location in the heart of the "Motor City," where nearly 300 guests, including officials from the Baden-Württemberg state government, the Ministry of Economic Affairs, the Stuttgart government, the German Chamber of Commerce, renowned trade and investment promotion organizations, and executives from German companies, gathered to discuss new opportunities for Sino-German cooperation. Hosted by the Taicang municipal government, this year's theme, "Innovation-Driven, Green Win-Win," highlighted Taicang's deepening ties with Germany across various sectors, including trade, education, culture, and sustainability. The event was a platform for fostering continued collaboration between both nations, with key discussions on shared innovation and sustainable development. In his opening
EMD's Retail Group further consolidates its position with Axfood from Sweden / The international retail alliance EMD is continuing to expand its importance in the cooperation with the A-brand industry25.6.2025 08:30:00 CEST | Pressemelding
Pfäffikon/Switzerland, 13/06/2025: By effectively combining forces to benefit its millions of retail customers, European Marketing Distribution (EMD) has risen to the top of the international trade alliances with this formula. The latest example of this successful strategy is the integration of the Swedish Axfood Group, an EMD member since 1995, which will join the EMD Retail Group in 2026. To clarify: while EMD and its member companies focus on the procurement and marketing of successful private label products, EMD members united in the Retail Group also implement cross-border services and marketing concepts in partnership with leading multinational A-brand manufacturers.
Börsenverein des Deutschen Buchhandels: Ulli Lust is awarded the German Non-Fiction Prize 2025 for “Die Frau als Mensch”17.6.2025 18:55:00 CEST | Press release
The winner of the German Non-Fiction Prize 2025 is Ulli Lust, for her work “Die Frau als Mensch. Am Anfang der Geschichte” (“Woman as Human. At the Dawn of History”) (Reprodukt).
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom